Change without breaking compliance
A manufacturing change filed one tier too low invites a warning letter. Filed one tier too high, it stalls your supply chain behind a supplement that never needed to exist. The hard part of change control is rarely the change itself; it is the judgment about how it must be assessed, classified, filed, and proven, across every market where the product is sold. We run that judgment as a discipline, so change becomes something your company does deliberately rather than something that happens to it.
Aligned to ICH Q10 change management: a controlled path where every change is assessed, routed, and verified before it touches a validated process.
Capture the change, its rationale, and its scope in a controlled record.
Structured ICH Q9 risk assessment against product quality and patient safety.
Determine the filing route in every affected market before committing.
Cross-functional review and quality approval with the evidence attached.
Execute against validated procedures, with regulatory filings sequenced correctly.
Confirm effectiveness and close the record with documented proof.
Classification sets your timeline, your filing burden, and your compliance exposure. We map each change to the correct tier in every market at once, so a single change never gets under-filed in one region while it waits on a supplement in another.
Low-risk changes implemented and reported after the fact. The trap is over-filing: escalating a minor change into a supplement that costs months and buys nothing.
Changes you may implement on a defined notice, absent objection. The judgment here is the finest: a mis-tiered moderate change is the most common source of compliance findings.
Changes that require approval before implementation. The work is protecting your timeline: strong justification, and comparability protocols that pre-lower future filings.
Classification is a defensible judgment, not a lookup. We document the reasoning behind every tier decision, so it holds up when an inspector, a partner, or a new market asks why a change was filed the way it was.
From a single supplier swap to a full change control system built from scratch, we run change as a program rather than a queue of tickets.
Process, equipment, site, specification, and formulation changes, classified and filed across every market the product reaches.
Supplier qualification, raw material and component substitutions, and the comparability work that keeps them from becoming supply interruptions.
Changes arising from deviations, CAPAs, and complaints, connected back to the quality events that triggered them so nothing is fixed twice.
Label, SmPC, and artwork changes controlled and version-tracked so every market shows exactly the approved text, and nothing else.
Comparability protocols that convert future major changes into lower filing tiers, buying back time on changes you already know are coming.
Designing, implementing, or remediating the change control system itself, so classification is consistent and the backlog stops growing.
We don't publish vanity metrics. We run to standards, and we put them in writing at the start of every engagement.
Every tier decision is documented with its reasoning at the moment it's made, so it holds up years later when an inspector or a new market partner asks why.
Over-filing is a cost, not caution. We classify to the tier the change actually warrants, and defend it, rather than escalating everything to avoid a hard call.
A change is assessed across all affected regions in a single pass, so it never ships compliant in one market and exposed in another.
A change isn't closed when it's made. It's closed when the record proves it worked and left the process in a validated state.
Our change control leads have made tier decisions, written the justifications, and stood behind them in front of FDA and EU inspectors. You aren't being staffed with junior consultants under a partner's name; you get the senior practitioner on every call.
Leads fluent in both the QMS mechanics of change and the regulatory filing consequences, because splitting the two is how changes get mis-tiered.
The lead consultant on your engagement is the one doing the work. We don't bait-and-switch with junior staff after the contract is signed.
Practitioners who have defended change decisions in real inspections, and who classify with that scrutiny in mind from the first record.
FDA supplements, EU variations, and national procedures handled together, so one change moves through every market on a single coherent plan.
Tell us about the change in front of you, or the change control system behind it. We'll match you with a senior quality and regulatory lead and respond within one business day. All inquiries are strictly confidential.